|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||||
| Cash and cash equivalents | |||||||
| Prepaid assets | |||||||
| Total current assets | |||||||
| Cash, cash equivalents and other investments held in Trust Account | |||||||
| Total assets | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||
| Current liabilities: | |||||||
| Accrued expenses, formation and offering costs | |||||||
| State franchise tax accrual | |||||||
| Income tax payable | |||||||
| Warrants derivative liability | |||||||
| Public Warrants | |||||||
| Private Placement Warrants | |||||||
| Notes and advances payable - related party | |||||||
| Total current liabilities | |||||||
| Deferred underwriting compensation | |||||||
| Total liabilities | |||||||
| Class A Common Stock subject to possible redemption, 46,000,000 and 46,000,000 shares at September 30, 2022 and December 31, 2021, respectively (at redemption value of $10.02 and $10.00 per share, respectively) | |||||||
| Stockholders’ equity (deficit): | |||||||
| Common stock value | |||||||
| Accumulated deficit | |||||||
| Class A Common Stock | |||||||
| Class F Common Stock | |||||||
| Total stockholders’ equity (deficit) | |||||||
| Total liabilities and stockholders’ equity (deficit) |
Loading...